BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 36222130)

  • 1. Knockdown of CBX7 inhibits ferroptosis in rats with cerebral ischemia and improves cognitive dysfunction by activating the Nrf2/HO-1 pathway.
    Zhang F; Lei F; Xiao X
    J Biosci; 2022; 47():. PubMed ID: 36222130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia.
    Fu C; Wu Y; Liu S; Luo C; Lu Y; Liu M; Wang L; Zhang Y; Liu X
    J Ethnopharmacol; 2022 May; 289():115021. PubMed ID: 35091012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection of chromobox 7 knockout in the mouse after cerebral ischemia-reperfusion injury via nuclear factor E2-related factor 2/hemeoxygenase-1 signaling pathway.
    Zhang HT; Wang XZ; Zhang QM; Zhao H
    Hum Exp Toxicol; 2022; 41():9603271221094660. PubMed ID: 35435747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection of chromobox 7 knockout in the mouse after cerebral ischemia-reperfusion injury via nuclear factor E2-related factor 2/hemeoxygenase-1 signaling pathway.
    Zhang HT; Wang XZ; Zhang QM; Zhao H
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S178-S186. PubMed ID: 34353139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhein attenuates cerebral ischemia-reperfusion injury via inhibition of ferroptosis through NRF2/SLC7A11/GPX4 pathway.
    Liu H; Zhang TA; Zhang WY; Huang SR; Hu Y; Sun J
    Exp Neurol; 2023 Nov; 369():114541. PubMed ID: 37714424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats.
    Hu Q; Zuo T; Deng L; Chen S; Yu W; Liu S; Liu J; Wang X; Fan X; Dong Z
    Phytomedicine; 2022 Jul; 102():154112. PubMed ID: 35550220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT5 Regulates Ferroptosis through the Nrf2/HO-1 Signaling Axis to Participate in Ischemia-Reperfusion Injury in Ischemic Stroke.
    Li J; Wei G; Song Z; Chen Z; Gu J; Zhang L; Wang Z
    Neurochem Res; 2024 Apr; 49(4):998-1007. PubMed ID: 38170384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loureirin C inhibits ferroptosis after cerebral ischemia reperfusion through regulation of the Nrf2 pathway in mice.
    Liu Y; Mi Y; Wang Y; Meng Q; Xu L; Liu Y; Zhou D; Wang Y; Liang D; Li W; Li N; Hou Y
    Phytomedicine; 2023 May; 113():154729. PubMed ID: 36878093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid alleviates cerebral ischemic injury in rats by resisting ferroptosis via Nrf2 signaling pathway.
    Li XN; Shang NY; Kang YY; Sheng N; Lan JQ; Tang JS; Wu L; Zhang JL; Peng Y
    Acta Pharmacol Sin; 2024 Feb; 45(2):248-267. PubMed ID: 37833536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shenmai Injection Attenuates Myocardial Ischemia/Reperfusion Injury by Targeting Nrf2/GPX4 Signalling-Mediated Ferroptosis.
    Mei SL; Xia ZY; Qiu Z; Jia YF; Zhou JJ; Zhou B
    Chin J Integr Med; 2022 Nov; 28(11):983-991. PubMed ID: 35997859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of gypenoside XVII against cerebral ischemia/reperfusion injury based on nuclear factor erythroid 2-related factor 2/antioxidant responsive element signaling pathway].
    Wang W; Xu Y; Xu S; Mao L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):293-298. PubMed ID: 36916343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edaravone dexborneol protects against cerebral ischemia/reperfusion-induced blood-brain barrier damage by inhibiting ferroptosis via activation of nrf-2/HO-1/GPX4 signaling.
    Xiao P; Huang H; Zhao H; Liu R; Sun Z; Liu Y; Chen N; Zhang Z
    Free Radic Biol Med; 2024 May; 217():116-125. PubMed ID: 38548187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperbaric oxygen improves cerebral ischemia-reperfusion injury in rats via inhibition of ferroptosis.
    Chen W; Zhou X; Meng M; Pan X; Huang L; Chen C
    J Stroke Cerebrovasc Dis; 2023 Dec; 32(12):107395. PubMed ID: 37839303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edaravone Ameliorates Cerebral Ischemia-Reperfusion Injury by Downregulating Ferroptosis via the Nrf2/FPN Pathway in Rats.
    Liu W; Wang L; Liu C; Dai Z; Li T; Tang B
    Biol Pharm Bull; 2022; 45(9):1269-1275. PubMed ID: 36047195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2 attenuates oxidative stress to mediate the protective effect of ciprofol against cerebral ischemia-reperfusion injury.
    Liu X; Ren M; Zhang A; Huang C; Wang J
    Funct Integr Genomics; 2023 Nov; 23(4):345. PubMed ID: 37996761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine exerts its protective effect on cerebral ischemia reperfusion injury in mice by inhibiting ferroptosis.
    Hu M; Men Y; Chen L; Huang J; Duan F; Zhang Y; Dong S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):600-609. PubMed ID: 35753730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farrerol Alleviates Hypoxic-Ischemic Encephalopathy by Inhibiting Ferroptosis in Neonatal Rats via the Nrf2 Pathway.
    Li Y; Wang T; Sun P; Zhu W; Chen Y; Chen M; Yang X; Du X; Zhao Y
    Physiol Res; 2023 Aug; 72(4):511-520. PubMed ID: 37795893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline protects against cerebral ischaemia-reperfusion injury through ferroptosis regulation via the Nrf2/SLC7A11/GPX4 signalling pathway.
    Li P; Chen JM; Ge SH; Sun ML; Lu JD; Liu F; Wang LL; Zhang X; Wang XP
    Eur J Pharmacol; 2024 Mar; 967():176402. PubMed ID: 38331339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diosmetin alleviated cerebral ischemia/reperfusion injury
    Mei Z; Du L; Liu X; Chen X; Tian H; Deng Y; Zhang W
    Food Funct; 2022 Jan; 13(1):198-212. PubMed ID: 34881386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway.
    Yang YY; Deng RR; Xiang DX
    Drug Des Devel Ther; 2024; 18():1499-1514. PubMed ID: 38716368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.